Osman Dönmez, Oguzhan Durmaz. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralAntiphospholipid Syndrome/complicationsAntiphospholipid Syndrome/pathologyAntiphospholipid Syndrome/physiopathologyAspirin/therapeutic useCalcinosis/drug therapyCalcinosis/etiologyCalcinosis/pathologyChildCyclosporine/therapeutic useDermatologic Agents/therapeutic useDiltiazem/therapeutic useDrug Therapy, CombinationEnoxaparin/therapeutic useFibrinolytic Agents/therapeutic useGlomerulonephritis, Membranoproliferative/complicationsGlomerulonephritis, Membranoproliferative/pathologyGlomerulonephritis, Membranoproliferative/physiopathologyGlucocorticoids/therapeutic useHumansLupus Erythematosus, Systemic/complicationsLupus Erythematosus, Systemic/pathologyLupus Erythematosus, Systemic/physiopathologyMaleSkin Ulcer/etiologySkin Ulcer/pathologySkin Ulcer/physiopathologyTreatment Outcome
Substances: See more » Dermatologic AgentsEnoxaparinFibrinolytic AgentsGlucocorticoidsCyclosporineDiltiazemAspirin
Year: 2010 PMID: 20130918 DOI: 10.1007/s00467-010-1441-1
Source DB: PubMed Journal: Pediatr Nephrol ISSN: 0931-041X Impact factor: 3.714